{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T00:53:33Z","timestamp":1792976013918,"version":"4.5.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100020309","name":"Vanderbilt Vision Research Center, Vanderbilt University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020309","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001209","name":"Knights Templar Eye Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001209","id-type":"DOI","asserted-by":"publisher"}]},{"name":"VUMC Clinical and Translational Science Award"},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R01 EY07533"],"award-info":[{"award-number":["R01 EY07533"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001694","name":"International Retinal Research Foundation","doi-asserted-by":"publisher","award":["GF02527"],"award-info":[{"award-number":["GF02527"]}],"id":[{"id":"10.13039\/100001694","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Children\u2019s Eye Foundation of the American Association for Pediatric Ophthalmology and Strabismus"},{"DOI":"10.13039\/100020526","name":"Vanderbilt Diabetes Research and Training Center, Vanderbilt University Medical Center","doi-asserted-by":"publisher","award":["P30 DK020593"],"award-info":[{"award-number":["P30 DK020593"]}],"id":[{"id":"10.13039\/100020526","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Angiogenesis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Diabetic retinopathy (DR) is characterized by chronic retinal inflammation and vascular remodeling that can threaten vision. Most current treatments are administered intravitreally and target vascular endothelial growth factor A (VEGF) but are often ineffective. Nevertheless, few alternative treatments, and no oral DR therapies, exist. Although IL-1\u03b2, TNF\u03b1, and IL-8 are upregulated along with VEGF within eyes with DR, they are not therapeutically targeted. IL-8 levels correlate with DR progression and resistance to anti-VEGF therapy, suggesting VEGF-independent contributions of IL-8-receptor signaling to DR. IL-1\u03b2 and TNF\u03b1, in turn, enhance expression of pro-angiogenic CXCR2 ligands (e.g. IL-8, CXCL1) in human M\u00fcller cells (hMC). Despite investigation of CXCR2 roles in several angiogenic and fibrotic diseases, CXCR2 inhibitors have not been explored in DR models. In this study, we show protein upregulation of IL-8 and CXCL1, but no detectable VEGF in conditioned media (CM) from IL-1\u03b2 and TNF\u03b1-stimulated hMC. Stimulation of human retinal microvascular endothelial cells (hRMEC) with this human M\u00fcller cell-conditioned media (hMC-CM), as well as directly with IL-8, upregulated hRMEC proliferation and migration. CXCR2 inhibition reduced pro-angiogenic hRMEC responses to hMC-CM and IL-8. Likewise, in vivo, in the oxygen-induced retinopathy (OIR) model, either genetic (\n                    <jats:italic>Cxcr2<\/jats:italic>\n                    <jats:sup>\n                      <jats:italic>-\/-<\/jats:italic>\n                    <\/jats:sup>\n                    ) or pharmacologic (SB225002) CXCR2 inhibition reduced pre-retinal neovascularization without altering avascularity or VEGF expression. These findings suggest that: (a) M\u00fcller cells may link inflammatory and angiogenic responses in the retina, (b) CXCR2 activation may contribute to DR, and (c) CXCR2 inhibitors may be repurposed to reduce pre-retinal neovascularization, a key feature of proliferative DR.\n                  <\/jats:p>","DOI":"10.1007\/s10456-025-10015-7","type":"journal-article","created":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T16:58:00Z","timestamp":1762016280000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["IL-8 receptor signaling as a novel target for angiogenic retinopathies"],"prefix":"10.1007","volume":"29","author":[{"given":"Maximilian J.","family":"Garcia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda L.","family":"Beall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica S.","family":"Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nolan J.","family":"Beatty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel A.","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marvarakumari","family":"Jhala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Drmanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Priest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyana","family":"Arellano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John S.","family":"Penn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolly A.","family":"Padovani-Claudio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,1]]},"reference":[{"issue":"5","key":"10015_CR1","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.preteyeres.2011.05.002","volume":"30","author":"J Tang","year":"2011","unstructured":"Tang J, Kern TS (2011) Inflammation in diabetic retinopathy. Prog Retin Eye Res 30(5):343\u2013358. https:\/\/doi.org\/10.1016\/j.preteyeres.2011.05.002","journal-title":"Prog Retin Eye Res"},{"issue":"11","key":"10015_CR2","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1016\/j.ophtha.2021.04.027","volume":"128","author":"ZL Teo","year":"2021","unstructured":"Teo ZL, Tham YC, Yu M, Chee ML, Rim TH, Cheung N, Bikbov MM, Wang YX, Tang Y, Lu Y, Wong IY, Ting DSW, Tan GSW, Jonas JB, Sabanayagam C, Wong TY, Cheng CY (2021) Global prevalence of diabetic retinopathy and projection of burden through 2045: systematic review and meta-analysis. Ophthalmology 128(11):1580\u20131591. https:\/\/doi.org\/10.1016\/j.ophtha.2021.04.027","journal-title":"Ophthalmology"},{"issue":"4","key":"10015_CR3","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.ophtha.2011.12.039","volume":"119","author":"QD Nguyen","year":"2012","unstructured":"Nguyen QD, Brown DM, Marcus DM, Boyer DS, Patel S, Feiner L, Gibson A, Sy J, Rundle AC, Hopkins JJ, Rubio RG, Ehrlich JS (2012) Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE. Ophthalmology 119(4):789\u2013801. https:\/\/doi.org\/10.1016\/j.ophtha.2011.12.039","journal-title":"Ophthalmology"},{"key":"10015_CR4","doi-asserted-by":"publisher","DOI":"10.4172\/2155-9899","author":"SF Abcouwer","year":"2013","unstructured":"Abcouwer SF (2013) Angiogenic factors and cytokines in diabetic retinopathy. J Clin Cell Immunol. https:\/\/doi.org\/10.4172\/2155-9899","journal-title":"J Clin Cell Immunol"},{"issue":"11","key":"10015_CR5","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.3109\/02713689508998529","volume":"14","author":"SG Elner","year":"1995","unstructured":"Elner SG, Elner VM, Jaffe GJ, Stuart A, Kunkel SL, Strieter RM (1995) Cytokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy. Curr Eye Res 14(11):1045\u20131053","journal-title":"Curr Eye Res"},{"issue":"13","key":"10015_CR6","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1056\/NEJMra1005073","volume":"366","author":"DA Antonetti","year":"2012","unstructured":"Antonetti DA, Klein R, Gardner TW (2012) Diabetic retinopathy. N Engl J Med 366(13):1227\u20131239. https:\/\/doi.org\/10.1056\/NEJMra1005073","journal-title":"N Engl J Med"},{"issue":"12","key":"10015_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0008158","volume":"4","author":"T Yoshimura","year":"2009","unstructured":"Yoshimura T, Sonoda KH, Sugahara M, Mochizuki Y, Enaida H, Oshima Y, Ueno A, Hata Y, Yoshida H, Ishibashi T (2009) Comprehensive analysis of inflammatory immune mediators in vitreoretinal diseases. PLoS ONE 4(12):e8158. https:\/\/doi.org\/10.1371\/journal.pone.0008158","journal-title":"PLoS ONE"},{"issue":"11","key":"10015_CR8","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1167\/iovs.65.11.37","volume":"65","author":"E Connolly","year":"2024","unstructured":"Connolly E, El-Farouki G, Brennan K, Cahill M, Doyle SL (2024) Poor Response to Bevacizumab Correlates With Higher IL-6 and IL-8 Aqueous Cytokines in AMD. Invest Ophthalmol Vis Sci 65(11):37. https:\/\/doi.org\/10.1167\/iovs.65.11.37","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"10015_CR9","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/eye.2016.287","volume":"31","author":"L Dong","year":"2017","unstructured":"Dong L, Bai J, Jiang X, Yang MM, Zheng Y, Zhang H, Lin D (2017) The gene polymorphisms of IL-8(-251T\/A) and IP-10(-1596C\/T) are associated with susceptibility and progression of type 2 diabetic retinopathy in northern Chinese population. Eye 31(4):601\u2013607. https:\/\/doi.org\/10.1038\/eye.2016.287","journal-title":"Eye"},{"issue":"17","key":"10015_CR10","doi-asserted-by":"publisher","first-page":"5783","DOI":"10.1158\/1078-0432.CCR-11-1115","volume":"17","author":"A Gerger","year":"2011","unstructured":"Gerger A, El-Khoueiry A, Zhang W, Yang D, Singh H, Bohanes P, Ning Y, Winder T, Labonte MJ, Wilson PM, Benhaim L, Paez D, El-Khoueiry R, Absenger G, Lenz HJ (2011) Pharmacogenetic angiogenesis profiling for first-line Bevacizumab plus oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Clin Cancer Res Off J Am Assoc Cancer Res 17(17):5783\u20135792. https:\/\/doi.org\/10.1158\/1078-0432.CCR-11-1115","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"issue":"1","key":"10015_CR11","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2217\/pgs.15.153","volume":"17","author":"S Lazzeri","year":"2016","unstructured":"Lazzeri S, Orlandi P, Piaggi P, Sartini MS, Casini G, Guidi G, Figus M, Fioravanti A, Di Desidero T, Ripandelli G, Parravano M, Varano M, Nardi M, Bocci G (2016) IL-8 and VEGFR-2 polymorphisms modulate long-term functional response to intravitreal ranibizumab in exudative age-related macular degeneration. Pharmacogenomics 17(1):35\u201339. https:\/\/doi.org\/10.2217\/pgs.15.153","journal-title":"Pharmacogenomics"},{"issue":"8","key":"10015_CR12","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1111\/aos.12799","volume":"93","author":"A Hautamaki","year":"2015","unstructured":"Hautamaki A, Seitsonen S, Holopainen JM, Moilanen JA, Kivioja J, Onkamo P, Jarvela I, Immonen I (2015) The genetic variant rs4073 A\u2013>T of the Interleukin-8 promoter region is associated with the earlier onset of exudative age-related macular degeneration. Acta Ophthalmol 93(8):726\u2013733. https:\/\/doi.org\/10.1111\/aos.12799","journal-title":"Acta Ophthalmol"},{"issue":"4","key":"10015_CR13","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1002\/ijc.27660","volume":"132","author":"KL Bondurant","year":"2013","unstructured":"Bondurant KL, Lundgreen A, Herrick JS, Kadlubar S, Wolff RK, Slattery ML (2013) Interleukin genes and associations with colon and rectal cancer risk and overall survival. Int J Cancer 132(4):905\u2013915. https:\/\/doi.org\/10.1002\/ijc.27660","journal-title":"Int J Cancer"},{"issue":"3","key":"10015_CR14","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1158\/0008-5472.CAN-14-2101","volume":"75","author":"BM Ryan","year":"2015","unstructured":"Ryan BM, Robles AI, McClary AC, Haznadar M, Bowman ED, Pine SR, Brown D, Khan M, Shiraishi K, Kohno T, Okayama H, Modali R, Yokota J, Harris CC (2015) Identification of a functional SNP in the 3\u2019UTR of CXCR2 that is associated with reduced risk of lung cancer. Cancer Res 75(3):566\u2013575. https:\/\/doi.org\/10.1158\/0008-5472.CAN-14-2101","journal-title":"Cancer Res"},{"issue":"9","key":"10015_CR15","doi-asserted-by":"publisher","first-page":"5269","DOI":"10.4049\/jimmunol.165.9.5269","volume":"165","author":"CL Addison","year":"2000","unstructured":"Addison CL, Daniel TO, Burdick MD, Liu H, Ehlert JE, Xue YY, Buechi L, Walz A, Richmond A, Strieter RM (2000) The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR+ CXC chemokine-induced angiogenic activity. J Immunol 165(9):5269\u20135277","journal-title":"J Immunol"},{"issue":"6","key":"10015_CR16","doi-asserted-by":"publisher","first-page":"3369","DOI":"10.4049\/jimmunol.170.6.3369","volume":"170","author":"A Li","year":"2003","unstructured":"Li A, Dubey S, Varney ML, Dave BJ, Singh RK (2003) IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis. J Immunol 170(6):3369\u20133376","journal-title":"J Immunol"},{"issue":"21","key":"10015_CR17","doi-asserted-by":"publisher","first-page":"6735","DOI":"10.1158\/1078-0432.CCR-07-4843","volume":"14","author":"DJ Waugh","year":"2008","unstructured":"Waugh DJ, Wilson C (2008) The interleukin-8 pathway in cancer. Clin Cancer Res Off J Am Assoc Cancer Res 14(21):6735\u20136741. https:\/\/doi.org\/10.1158\/1078-0432.CCR-07-4843","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"issue":"10","key":"10015_CR18","doi-asserted-by":"publisher","first-page":"6038","DOI":"10.1074\/jbc.C800207200","volume":"284","author":"D Martin","year":"2009","unstructured":"Martin D, Galisteo R, Gutkind JS (2009) CXCL8\/IL8 stimulates vascular endothelial growth factor (VEGF) expression and the autocrine activation of VEGFR2 in endothelial cells by activating NFkappaB through the CBM (Carma3\/Bcl10\/Malt1) complex. J Biol Chem 284(10):6038\u20136042. https:\/\/doi.org\/10.1074\/jbc.C800207200","journal-title":"J Biol Chem"},{"issue":"4","key":"10015_CR19","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1080\/02713680590923276","volume":"30","author":"MR Powers","year":"2005","unstructured":"Powers MR, Davies MH, Eubanks JP (2005) Increased expression of chemokine KC, an interleukin-8 homologue, in a model of oxygen-induced retinopathy. Curr Eye Res 30(4):299\u2013307. https:\/\/doi.org\/10.1080\/02713680590923276","journal-title":"Curr Eye Res"},{"issue":"2","key":"10015_CR20","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1046\/j.1523-1747.2000.00034.x","volume":"115","author":"RM Devalaraja","year":"2000","unstructured":"Devalaraja RM, Nanney LB, Du J, Qian Q, Yu Y, Devalaraja MN, Richmond A (2000) Delayed wound healing in CXCR2 knockout mice. J Invest Dermatol 115(2):234\u2013244. https:\/\/doi.org\/10.1046\/j.1523-1747.2000.00034.x","journal-title":"J Invest Dermatol"},{"issue":"1","key":"10015_CR21","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.expneurol.2009.07.010","volume":"220","author":"AE Kerstetter","year":"2009","unstructured":"Kerstetter AE, Padovani-Claudio DA, Bai L, Miller RH (2009) Inhibition of CXCR2 signaling promotes recovery in models of multiple sclerosis. Exp Neurol 220(1):44\u201356. https:\/\/doi.org\/10.1016\/j.expneurol.2009.07.010","journal-title":"Exp Neurol"},{"issue":"10","key":"10015_CR22","doi-asserted-by":"publisher","first-page":"4578","DOI":"10.1167\/iovs.08-1887","volume":"49","author":"I Goczalik","year":"2008","unstructured":"Goczalik I, Ulbricht E, Hollborn M, Raap M, Uhlmann S, Weick M, Pannicke T, Wiedemann P, Bringmann A, Reichenbach A, Francke M (2008) Expression of CXCL8, CXCR1, and CXCR2 in neurons and glial cells of the human and rabbit retina. Invest Ophthalmol Vis Sci 49(10):4578\u20134589. https:\/\/doi.org\/10.1167\/iovs.08-1887","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"10015_CR23","doi-asserted-by":"publisher","first-page":"2676","DOI":"10.1167\/iovs.06-0598","volume":"48","author":"JR Smith","year":"2007","unstructured":"Smith JR, Choi D, Chipps TJ, Pan Y, Zamora DO, Davies MH, Babra B, Powers MR, Planck SR, Rosenbaum JT (2007) Unique gene expression profiles of donor-matched human retinal and choroidal vascular endothelial cells. Invest Ophthalmol Vis Sci 48(6):2676\u20132684. https:\/\/doi.org\/10.1167\/iovs.06-0598","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10015_CR24","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/nrd2734","volume":"8","author":"R Horuk","year":"2009","unstructured":"Horuk R (2009) Chemokine receptor antagonists: overcoming developmental hurdles. Nat Rev Drug Discovery 8(1):23\u201333. https:\/\/doi.org\/10.1038\/nrd2734","journal-title":"Nat Rev Drug Discovery"},{"issue":"3","key":"10015_CR25","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.bcp.2004.10.007","volume":"69","author":"F Casilli","year":"2005","unstructured":"Casilli F, Bianchini A, Gloaguen I, Biordi L, Alesse E, Festuccia C, Cavalieri B, Strippoli R, Cervellera MN, Di Bitondo R, Ferretti E, Mainiero F, Bizzarri C, Colotta F, Bertini R (2005) Inhibition of interleukin-8 (CXCL8\/IL-8) responses by repertaxin, a new inhibitor of the chemokine receptors CXCR1 and CXCR2. Biochem Pharmacol 69(3):385\u2013394. https:\/\/doi.org\/10.1016\/j.bcp.2004.10.007","journal-title":"Biochem Pharmacol"},{"issue":"1\u20132","key":"10015_CR26","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.imlet.2012.04.003","volume":"145","author":"M Allegretti","year":"2012","unstructured":"Allegretti M, Cesta MC, Garin A, Proudfoot AE (2012) Current status of chemokine receptor inhibitors in development. Immunol Lett 145(1\u20132):68\u201378. https:\/\/doi.org\/10.1016\/j.imlet.2012.04.003","journal-title":"Immunol Lett"},{"key":"10015_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2022.101151","volume":"94","author":"DA Padovani-Claudio","year":"2023","unstructured":"Padovani-Claudio DA, Ramos CJ, Capozzi ME, Penn JS (2023) Elucidating glial responses to products of diabetes-associated systemic dyshomeostasis. Prog Retin Eye Res 94:101151. https:\/\/doi.org\/10.1016\/j.preteyeres.2022.101151","journal-title":"Prog Retin Eye Res"},{"key":"10015_CR28","doi-asserted-by":"publisher","first-page":"771571","DOI":"10.3389\/fphar.2021.771571","volume":"12","author":"A Schmalen","year":"2021","unstructured":"Schmalen A, Lorenz L, Grosche A, Pauly V, Deeg CA (2021) Hauck SM (2021) Proteomic phenotyping of stimulated muller cells uncovers profound pro-inflammatory signaling and antigen-presenting capacity. Front Pharmacol 12:771571. https:\/\/doi.org\/10.3389\/fphar.2021.771571","journal-title":"Front Pharmacol"},{"issue":"4","key":"10015_CR29","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.preteyeres.2006.05.003","volume":"25","author":"A Bringmann","year":"2006","unstructured":"Bringmann A, Pannicke T, Grosche J, Francke M, Wiedemann P, Skatchkov SN, Osborne NN, Reichenbach A (2006) Muller cells in the healthy and diseased retina. Prog Retin Eye Res 25(4):397\u2013424. https:\/\/doi.org\/10.1016\/j.preteyeres.2006.05.003","journal-title":"Prog Retin Eye Res"},{"issue":"1","key":"10015_CR30","doi-asserted-by":"publisher","first-page":"26159","DOI":"10.1038\/s41598-024-75532-9","volume":"14","author":"MJ Garcia","year":"2024","unstructured":"Garcia MJ, Morales MS, Yang TS, Holden J, Bossardet OL, Palmer SA, Jhala M, Priest S, Namburu N, Beatty N, D\u2019Empaire Salomon SE, Vancel J, Wareham LK, Padovani-Claudio DA (2024) Adverse effects of CXCR2 deficiency in mice reared under non-gnotobiotic conditions. Sci Rep 14(1):26159. https:\/\/doi.org\/10.1038\/s41598-024-75532-9","journal-title":"Sci Rep"},{"key":"10015_CR31","doi-asserted-by":"publisher","first-page":"67","DOI":"10.2147\/EB.S94447","volume":"8","author":"CB Kim","year":"2016","unstructured":"Kim CB, D\u2019Amore PA, Connor KM (2016) Revisiting the mouse model of oxygen-induced retinopathy. Eye Brain 8:67\u201379. https:\/\/doi.org\/10.2147\/EB.S94447","journal-title":"Eye Brain"},{"issue":"6","key":"10015_CR32","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.2353\/ajpath.2010.100526","volume":"177","author":"A Stahl","year":"2010","unstructured":"Stahl A, Chen J, Sapieha P, Seaward MR, Krah NM, Dennison RJ, Favazza T, Bucher F, Lofqvist C, Ong H, Hellstrom A, Chemtob S, Akula JD, Smith LE (2010) Postnatal weight gain modifies severity and functional outcome of oxygen-induced proliferative retinopathy. Am J Pathol 177(6):2715\u20132723. https:\/\/doi.org\/10.2353\/ajpath.2010.100526","journal-title":"Am J Pathol"},{"issue":"1","key":"10015_CR33","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1167\/iovs.05-0673","volume":"47","author":"JS Penn","year":"2006","unstructured":"Penn JS, McCollum GW, Barnett JM, Werdich XQ, Koepke KA, Rajaratnam VS (2006) Angiostatic effect of penetrating ocular injury: role of pigment epithelium-derived factor. Invest Ophthalmol Vis Sci 47(1):405\u2013414. https:\/\/doi.org\/10.1167\/iovs.05-0673","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"10015_CR34","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/0039-128x(82)90068-x","volume":"39","author":"PG Campbell","year":"1982","unstructured":"Campbell PG, Pritchett JF, Marple DN, Till ML, Rahe CH (1982) Characterization of [3H] corticosterone binding activity in adrenal incubation media. Steroids 39(4):445\u2013452. https:\/\/doi.org\/10.1016\/0039-128x(82)90068-x","journal-title":"Steroids"},{"issue":"1","key":"10015_CR35","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1038\/s42003-023-04905-z","volume":"6","author":"G Kaur","year":"2023","unstructured":"Kaur G, Sharma D, Bisen S, Mukhopadhyay CS, Gurdziel K, Singh NK (2023) Vascular cell-adhesion molecule 1 (VCAM-1) regulates JunB-mediated IL-8\/CXCL1 expression and pathological neovascularization. Commun Biol 6(1):516. https:\/\/doi.org\/10.1038\/s42003-023-04905-z","journal-title":"Commun Biol"},{"key":"10015_CR36","doi-asserted-by":"publisher","unstructured":"Yoshida S, Yoshida A, Ishibashi T (2004) Induction of IL-8, MCP-1, and bFGF by TNF-alpha in retinal glial cells: implications for retinal neovascularization during post-ischemic inflammation. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 242 (5):409\u2013413. https:\/\/doi.org\/10.1007\/s00417-004-0874-2","DOI":"10.1007\/s00417-004-0874-2"},{"key":"10015_CR37","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/817038","volume":"2015","author":"I Naegelen","year":"2015","unstructured":"Naegelen I, Beaume N, Plancon S, Schenten V, Tschirhart EJ, Brechard S (2015) Regulation of Neutrophil degranulation and cytokine secretion: a novel model approach based on linear fitting. J Immunol Res 2015:817038. https:\/\/doi.org\/10.1155\/2015\/817038","journal-title":"J Immunol Res"},{"issue":"8","key":"10015_CR38","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1182\/blood.V96.8.2673","volume":"96","author":"PE Van den Steen","year":"2000","unstructured":"Van den Steen PE, Proost P, Wuyts A, Van Damme J, Opdenakker G (2000) Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-alpha and leaves RANTES and MCP-2 intact. Blood 96(8):2673\u20132681","journal-title":"Blood"},{"issue":"4","key":"10015_CR39","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1083\/jcb.200409115","volume":"169","author":"S Lee","year":"2005","unstructured":"Lee S, Jilani SM, Nikolova GV, Carpizo D, Iruela-Arispe ML (2005) Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors. J Cell Biol 169(4):681\u2013691. https:\/\/doi.org\/10.1083\/jcb.200409115","journal-title":"J Cell Biol"},{"issue":"25","key":"10015_CR40","doi-asserted-by":"publisher","first-page":"14657","DOI":"10.1074\/jbc.271.25.14657","volume":"271","author":"A Ito","year":"1996","unstructured":"Ito A, Mukaiyama A, Itoh Y, Nagase H, Thogersen IB, Enghild JJ, Sasaguri Y, Mori Y (1996) Degradation of interleukin 1beta by matrix metalloproteinases. J Biol Chem 271(25):14657\u201314660. https:\/\/doi.org\/10.1074\/jbc.271.25.14657","journal-title":"J Biol Chem"},{"issue":"5","key":"10015_CR41","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.jdiacomp.2007.03.001","volume":"22","author":"C Gustavsson","year":"2008","unstructured":"Gustavsson C, Agardh E, Bengtsson B, Agardh CD (2008) TNF-alpha is an independent serum marker for proliferative retinopathy in type 1 diabetic patients. J Diabetes Complic 22(5):309\u2013316. https:\/\/doi.org\/10.1016\/j.jdiacomp.2007.03.001","journal-title":"J Diabetes Complic"},{"issue":"1","key":"10015_CR42","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1189\/jlb.0605353","volume":"79","author":"S Chakrabarti","year":"2006","unstructured":"Chakrabarti S, Zee JM, Patel KD (2006) Regulation of matrix metalloproteinase-9 (MMP-9) in TNF-stimulated neutrophils: novel pathways for tertiary granule release. J Leukoc Biol 79(1):214\u2013222. https:\/\/doi.org\/10.1189\/jlb.0605353","journal-title":"J Leukoc Biol"},{"issue":"1","key":"10015_CR43","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1593\/tlo.10184","volume":"4","author":"A Li","year":"2011","unstructured":"Li A, Cheng XJ, Moro A, Singh RK, Hines OJ, Eibl G (2011) CXCR2-dependent endothelial progenitor cell mobilization in pancreatic cancer growth. Transl Oncol 4(1):20\u201328","journal-title":"Transl Oncol"},{"issue":"8","key":"10015_CR44","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1084\/jem.186.8.1201","volume":"186","author":"I Desbaillets","year":"1997","unstructured":"Desbaillets I, Diserens AC, Tribolet N, Hamou MF, Van Meir EG (1997) Upregulation of interleukin 8 by oxygen-deprived cells in glioblastoma suggests a role in leukocyte activation, chemotaxis, and angiogenesis. J Exp Med 186(8):1201\u20131212","journal-title":"J Exp Med"},{"issue":"1","key":"10015_CR45","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.pharmthera.2008.10.005","volume":"121","author":"RW Chapman","year":"2009","unstructured":"Chapman RW, Phillips JE, Hipkin RW, Curran AK, Lundell D, Fine JS (2009) CXCR2 antagonists for the treatment of pulmonary disease. Pharmacol Ther 121(1):55\u201368. https:\/\/doi.org\/10.1016\/j.pharmthera.2008.10.005","journal-title":"Pharmacol Ther"},{"issue":"9","key":"10015_CR46","doi-asserted-by":"publisher","first-page":"3127","DOI":"10.1172\/JCI61067","volume":"122","author":"T Jamieson","year":"2012","unstructured":"Jamieson T, Clarke M, Steele CW, Samuel MS, Neumann J, Jung A, Huels D, Olson MF, Das S, Nibbs RJ, Sansom OJ (2012) Inhibition of CXCR2 profoundly suppresses inflammation-driven and spontaneous tumorigenesis. J Clin Investig 122(9):3127\u20133144. https:\/\/doi.org\/10.1172\/JCI61067","journal-title":"J Clin Investig"},{"issue":"8","key":"10015_CR47","doi-asserted-by":"publisher","first-page":"5351","DOI":"10.4049\/jimmunol.175.8.5351","volume":"175","author":"J Mestas","year":"2005","unstructured":"Mestas J, Burdick MD, Reckamp K, Pantuck A, Figlin RA, Strieter RM (2005) The role of CXCR2\/CXCR2 ligand biological axis in renal cell carcinoma. J Immunol 175(8):5351\u20135357","journal-title":"J Immunol"},{"issue":"6","key":"10015_CR48","doi-asserted-by":"publisher","first-page":"L1117","DOI":"10.1152\/ajplung.00370.2004","volume":"288","author":"A Moldobaeva","year":"2005","unstructured":"Moldobaeva A, Wagner EM (2005) Difference in proangiogenic potential of systemic and pulmonary endothelium: role of CXCR2. Am J Physiol Lung Cell Mol Physiol 288(6):L1117-1123. https:\/\/doi.org\/10.1152\/ajplung.00370.2004","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"3","key":"10015_CR49","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/jcbfm.2009.240","volume":"30","author":"BD Semple","year":"2010","unstructured":"Semple BD, Kossmann T, Morganti-Kossmann MC (2010) Role of chemokines in CNS health and pathology: a focus on the CCL2\/CCR2 and CXCL8\/CXCR2 networks. J Cereb Blood Flow Metab Off J Int Soc Cereb Blood Flow Metab 30(3):459\u2013473. https:\/\/doi.org\/10.1038\/jcbfm.2009.240","journal-title":"J Cereb Blood Flow Metab Off J Int Soc Cereb Blood Flow Metab"},{"issue":"15","key":"10015_CR50","doi-asserted-by":"publisher","first-page":"3875","DOI":"10.1158\/1078-0432.CCR-10-0483","volume":"16","author":"G Yang","year":"2010","unstructured":"Yang G, Rosen DG, Liu G, Yang F, Guo X, Xiao X, Xue F, Mercado-Uribe I, Huang J, Lin SH, Mills GB, Liu J (2010) CXCR2 promotes ovarian cancer growth through dysregulated cell cycle, diminished apoptosis, and enhanced angiogenesis. Clin Cancer Res Off J Am Assoc Cancer Res 16(15):3875\u20133886. https:\/\/doi.org\/10.1158\/1078-0432.CCR-10-0483","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"issue":"11","key":"10015_CR51","first-page":"1399","volume":"23","author":"S Zaja-Milatovic","year":"2008","unstructured":"Zaja-Milatovic S, Richmond A (2008) CXC chemokines and their receptors: a case for a significant biological role in cutaneous wound healing. Histol Histopathol 23(11):1399\u20131407","journal-title":"Histol Histopathol"},{"issue":"6","key":"10015_CR52","doi-asserted-by":"publisher","first-page":"L1094","DOI":"10.1152\/ajplung.2001.280.6.L1094","volume":"280","author":"IU Schraufstatter","year":"2001","unstructured":"Schraufstatter IU, Chung J, Burger M (2001) IL-8 activates endothelial cell CXCR1 and CXCR2 through Rho and Rac signaling pathways. Am J Physiol Lung Cell Mol Physiol 280(6):L1094-1103","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"6","key":"10015_CR53","doi-asserted-by":"publisher","first-page":"2904","DOI":"10.4049\/jimmunol.170.6.2904","volume":"170","author":"RM Richardson","year":"2003","unstructured":"Richardson RM, Marjoram RJ, Barak LS, Snyderman R (2003) Role of the cytoplasmic tails of CXCR1 and CXCR2 in mediating leukocyte migration, activation, and regulation. J Immunol 170(6):2904\u20132911","journal-title":"J Immunol"},{"issue":"2","key":"10015_CR54","first-page":"575","volume":"7","author":"LB Liu","year":"2014","unstructured":"Liu LB, Xie F, Chang KK, Li MQ, Meng YH, Wang XH, Li H, Li DJ, Yu JJ (2014) Hypoxia promotes the proliferation of cervical carcinoma cells through stimulating the secretion of IL-8. Int J Clin Exp Pathol 7(2):575\u2013583","journal-title":"Int J Clin Exp Pathol"},{"issue":"4","key":"10015_CR55","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/ijc.24040","volume":"124","author":"Y Matsuo","year":"2009","unstructured":"Matsuo Y, Ochi N, Sawai H, Yasuda A, Takahashi H, Funahashi H, Takeyama H, Tong Z, Guha S (2009) CXCL8\/IL-8 and CXCL12\/SDF-1alpha co-operatively promote invasiveness and angiogenesis in pancreatic cancer. Int J Cancer 124(4):853\u2013861. https:\/\/doi.org\/10.1002\/ijc.24040","journal-title":"Int J Cancer"},{"issue":"9","key":"10015_CR56","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1128\/MCB.01304-08","volume":"29","author":"J Gavard","year":"2009","unstructured":"Gavard J, Hou X, Qu Y, Masedunskas A, Martin D, Weigert R, Li X, Gutkind JS (2009) A role for a CXCR2\/phosphatidylinositol 3-kinase gamma signaling axis in acute and chronic vascular permeability. Mol Cell Biol 29(9):2469\u20132480. https:\/\/doi.org\/10.1128\/MCB.01304-08","journal-title":"Mol Cell Biol"},{"key":"10015_CR57","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.754933","volume":"12","author":"P Ma","year":"2021","unstructured":"Ma P, Zhang P, Chen S, Shi W, Ye J, Chen S, Ju R, Liu B, Zheng Y, Liu Y (2021) Immune cell landscape of patients with diabetic macular edema by single-cell RNA analysis. Front Pharmacol 12:754933. https:\/\/doi.org\/10.3389\/fphar.2021.754933","journal-title":"Front Pharmacol"},{"issue":"8","key":"10015_CR58","first-page":"742","volume":"45","author":"Y Qu","year":"2009","unstructured":"Qu Y, Zhou F, Xu XY (2009) Selective non-peptide CXCR2 antagonist SB225002 inhibits choroidal neovascularization in rat model. Zhonghua Yan Ke Za Zhi 45(8):742\u2013745","journal-title":"Zhonghua Yan Ke Za Zhi"},{"key":"10015_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102438","volume":"56","author":"S Wang","year":"2022","unstructured":"Wang S, Bai J, Zhang YL, Lin QY, Han X, Qu WK, Zhang PF, Ge YS, Zhao Q, Li HH (2022) CXCL1-CXCR2 signalling mediates hypertensive retinopathy by inducing macrophage infiltration. Redox Biol 56:102438. https:\/\/doi.org\/10.1016\/j.redox.2022.102438","journal-title":"Redox Biol"},{"issue":"3","key":"10015_CR60","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.mvr.2011.06.011","volume":"82","author":"S Singh","year":"2011","unstructured":"Singh S, Wu S, Varney M, Singh AP, Singh RK (2011) CXCR1 and CXCR2 silencing modulates CXCL8-dependent endothelial cell proliferation, migration and capillary-like structure formation. Microvasc Res 82(3):318\u2013325. https:\/\/doi.org\/10.1016\/j.mvr.2011.06.011","journal-title":"Microvasc Res"},{"issue":"2","key":"10015_CR61","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1159\/000342977","volume":"49","author":"UE Koskela","year":"2013","unstructured":"Koskela UE, Kuusisto SM, Nissinen AE, Savolainen MJ, Liinamaa MJ (2013) High vitreous concentration of IL-6 and IL-8, but not of adhesion molecules in relation to plasma concentrations in proliferative diabetic retinopathy. Ophthalm Res 49(2):108\u2013114. https:\/\/doi.org\/10.1159\/000342977","journal-title":"Ophthalm Res"},{"issue":"9","key":"10015_CR62","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0203408","volume":"13","author":"JW Kwon","year":"2018","unstructured":"Kwon JW, Jee D (2018) Aqueous humor cytokine levels in patients with diabetic macular edema refractory to anti-VEGF treatment. PLoS ONE 13(9):e0203408. https:\/\/doi.org\/10.1371\/journal.pone.0203408","journal-title":"PLoS ONE"},{"issue":"6","key":"10015_CR63","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0066978","volume":"8","author":"F Ricci","year":"2013","unstructured":"Ricci F, Staurenghi G, Lepre T, Missiroli F, Zampatti S, Cascella R, Borgiani P, Marsella LT, Eandi CM, Cusumano A, Novelli G, Giardina E (2013) Haplotypes in IL-8 gene are associated to age-related macular degeneration: a case-control study. PLoS ONE 8(6):e66978. https:\/\/doi.org\/10.1371\/journal.pone.0066978","journal-title":"PLoS ONE"},{"issue":"12","key":"10015_CR64","doi-asserted-by":"publisher","first-page":"5552","DOI":"10.1167\/iovs.09-3694","volume":"50","author":"S Abhary","year":"2009","unstructured":"Abhary S, Burdon KP, Gupta A, Lake S, Selva D, Petrovsky N, Craig JE (2009) Common sequence variation in the VEGFA gene predicts risk of diabetic retinopathy. Invest Ophthalmol Vis Sci 50(12):5552\u20135558. https:\/\/doi.org\/10.1167\/iovs.09-3694","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10015_CR65","doi-asserted-by":"publisher","first-page":"3727","DOI":"10.2147\/OTT.S103159","volume":"9","author":"M Zhang","year":"2016","unstructured":"Zhang M, Fang T, Wang K, Mei H, Lv Z, Wang F, Cai Z, Liang C (2016) Association of polymorphisms in interleukin-8 gene with cancer risk: a meta-analysis of 22 case-control studies. Onco Targets Ther 9:3727\u20133737. https:\/\/doi.org\/10.2147\/OTT.S103159","journal-title":"Onco Targets Ther"},{"issue":"4","key":"10015_CR66","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1016\/j.gendis.2022.10.017","volume":"10","author":"D Huang","year":"2023","unstructured":"Huang D, Liu G, Xu Z, Chen S, Wang C, Liu D, Cao J, Cheng J, Wu B, Wu D (2023) The multifaceted role of placental growth factor in the pathogenesis and progression of bronchial asthma and pulmonary fibrosis: Therapeutic implications. Genes Dis 10(4):1537\u20131551. https:\/\/doi.org\/10.1016\/j.gendis.2022.10.017","journal-title":"Genes Dis"},{"key":"10015_CR67","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.bcp.2019.07.021","volume":"168","author":"F Lazzara","year":"2019","unstructured":"Lazzara F, Fidilio A, Platania CBM, Giurdanella G, Salomone S, Leggio GM, Tarallo V, Cicatiello V, De Falco S, Eandi CM, Drago F, Bucolo C (2019) Aflibercept regulates retinal inflammation elicited by high glucose via the PlGF\/ERK pathway. Biochem Pharmacol 168:341\u2013351. https:\/\/doi.org\/10.1016\/j.bcp.2019.07.021","journal-title":"Biochem Pharmacol"},{"issue":"17","key":"10015_CR68","doi-asserted-by":"publisher","first-page":"3984","DOI":"10.1021\/jm061469t","volume":"50","author":"A Moriconi","year":"2007","unstructured":"Moriconi A, Cesta MC, Cervellera MN, Aramini A, Coniglio S, Colagioia S, Beccari AR, Bizzarri C, Cavicchia MR, Locati M, Galliera E, Di Benedetto P, Vigilante P, Bertini R, Allegretti M (2007) Design of noncompetitive interleukin-8 inhibitors acting on CXCR1 and CXCR2. J Med Chem 50(17):3984\u20134002. https:\/\/doi.org\/10.1021\/jm061469t","journal-title":"J Med Chem"},{"issue":"32","key":"10015_CR69","doi-asserted-by":"publisher","first-page":"11791","DOI":"10.1073\/pnas.0402090101","volume":"101","author":"R Bertini","year":"2004","unstructured":"Bertini R, Allegretti M, Bizzarri C, Moriconi A, Locati M, Zampella G, Cervellera MN, Di Cioccio V, Cesta MC, Galliera E, Martinez FO, Di Bitondo R, Troiani G, Sabbatini V, D\u2019Anniballe G, Anacardio R, Cutrin JC, Cavalieri B, Mainiero F, Strippoli R, Villa P, Di Girolamo M, Martin F, Gentile M, Santoni A, Corda D, Poli G, Mantovani A, Ghezzi P, Colotta F (2004) Noncompetitive allosteric inhibitors of the inflammatory chemokine receptors CXCR1 and CXCR2: prevention of reperfusion injury. Proc Natl Acad Sci USA 101(32):11791\u201311796. https:\/\/doi.org\/10.1073\/pnas.0402090101","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"10015_CR70","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/0014-4835(90)90063-z","volume":"51","author":"D Hicks","year":"1990","unstructured":"Hicks D, Courtois Y (1990) The growth and behaviour of rat retinal Muller cells in vitro. 1. An improved method for isolation and culture. Exp Eye Res 51(2):119\u2013129. https:\/\/doi.org\/10.1016\/0014-4835(90)90063-z","journal-title":"Exp Eye Res"},{"key":"10015_CR71","doi-asserted-by":"publisher","unstructured":"Committee U (2011). In: Guide for the Care and Use of Laboratory Animals. The National Academies Collection: Reports funded by National Institutes of Health, 8th edn., Washington (DC). https:\/\/doi.org\/10.17226\/12910","DOI":"10.17226\/12910"},{"issue":"5172","key":"10015_CR72","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1126\/science.8036519","volume":"265","author":"G Cacalano","year":"1994","unstructured":"Cacalano G, Lee J, Kikly K, Ryan AM, Pitts-Meek S, Hultgren B, Wood WI, Moore MW (1994) Neutrophil and B cell expansion in mice that lack the murine IL-8 receptor homolog. Science 265(5172):682\u2013684. https:\/\/doi.org\/10.1126\/science.8036519","journal-title":"Science"}],"container-title":["Angiogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10456-025-10015-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10456-025-10015-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10456-025-10015-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T16:58:02Z","timestamp":1762016282000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10456-025-10015-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,1]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["10015"],"URL":"https:\/\/doi.org\/10.1007\/s10456-025-10015-7","relation":{},"ISSN":["1573-7209"],"issn-type":[{"value":"1573-7209","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,1]]},"assertion":[{"value":"22 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All animal studies were conducted in accordance with the Guide for the Care and Use of Laboratory Animals, though a protocol approved by the IACUC at Vanderbilt University Medical Center (VUMC) and reported in accordance with ARRIVE guidelines. All data and findings adhered to the minimum reporting guidelines hosted by the EQUATOR Network.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"De-identified eye tissue samples were collected through the National Disease Research Interchange (NDRI) for the isolation of primary human M\u00fcller cells. NDRI requires that informed consent be obtained in writing from any tissue donor or next-of-kin for the use of tissue in research. A signed consent\/authorization remains on file at the tissue acquisition site. For more information, visit\n                      \n                      or call 1(800)-222-6374.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"2"}}